Clinical Trial

A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study is testing the safety, tolerability, pharmacokinetics and pharmacodynamics of GB-0895.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-04.
Status change: Recruiting → Active, Not Recruiting 2025-11-04
Trial Details
NCT Number NCT07116889
Lead Sponsor Generate Biomedicines
Conditions Asthma, COPD (Chronic Obstructive Pulmonary Disease)
Enrollment 156 participants
Start Date 2023-12-12
Primary Completion 2027-05 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2025-11-05